SCHEMBL23917244

SCHEMBL23917244

CC(=O)c1cccc(-c2nn(C)c3ncnc(N)c23)c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 14/20 0.74
PIK3CA P42336 14/20 0.74
PIK3CB P42338 14/20 0.74
PIK3CG P48736 14/20 0.74
PRKDC P78527 14/20 0.74
SRC P12931 14/20 0.74
ABL1 P00519 13/20 0.74
EGFR P00533 13/20 0.74
HCK P08631 13/20 0.74
MTOR P42345 13/20 0.74
EPHB4 P54760 13/20 0.74
KDR P35968 12/20 0.74
PI4KB Q9UBF8 6/20 0.74
AURKA O14965 1/20 0.59
IKBKE Q14164 1/20 0.59
AURKB Q96GD4 1/20 0.59
NUDT14 O95848 1/20 0.53
NUDT5 Q9UKK9 1/20 0.53
RIPK1 Q13546 3/20 0.49
RICTOR Q6R327 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23917238 0.91 PIK3CD (0.68) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL17970700 0.85 AURKA (0.67) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL2469922 0.85 SRC (1.00) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL130427 0.85 PIK3CD (0.72) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL130623 0.83 PIK3CD (0.58) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL130589 0.83 PIK3CG (0.74) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL130421 0.82 PIK3CD (0.78) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL130485 0.82 PIK3CA (0.57) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL129820 0.81 PIK3CD (0.76) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL12351 0.80 PIK3CD (0.74) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210317140-A1 Heterocyclic Compounds and Methods of Use MEDIVATION TECHNOLOGIES, INC. (US) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317140-A1 Heterocyclic Compounds and Methods of Use BTK, PIK3CD, PIK3CB PIK3CD 2/4885PIK3CA 6/4885PIK3CB 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.